News

Brazil-based Engefiltro, which has filtration systems engineering capabilities, has presence across various industries including pharma. This expertise increases Pall’s regional capabilities in the design, construction and servicing of

Aptalis Pharma will offer Zenpep in 25,000 units of lipase for pateints with exocrine pancreatic insufficiency (EPI) caused by CF or other conditions. Aptalis Pharma president and CEO

The joint venture, which is a 50-50 partnership deal, is expected to provide active pharmaceutical ingredients (API) to various other pharmaceutical firms. With this manufacturing plant, the companies

The marketing authorization was granted on the basis of the results of three Phase 3 trials evaluating XGEVA versus zoledronic acid at delaying SREs. The results of the

The committee has also given 100% vote and recommended the FDA to also approve Adcetris as a treatment for patients with relapsed or refractory systemic anaplastic large cell

HealOr is a developer of new treatments for acute and chronic wounds such as diabetic foot ulcer (DFU), psoriasis and others. Most recently, Sabolinski has worked as the

The trascation allows BPTC to introduce Angel to new customers that require the advanced cell therapy development and cGMP manufacturing services. The agreement will facilitate to expand Angel’s

Vascazen is a prescription medical food formulated to meet the dietary omega-3 deficient needs of patients with cardiovascular disease through elevating Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) to levels

The drug has been given approval for its 37.5mg, 75mg and 150mg dosage strengths. Venlafaxine ER capsules are indicated for the treatment of major depressive disorder (MDD) and